Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Aug 20;17(1):115.
doi: 10.1186/s13058-015-0628-6.

Lack of epidermal growth factor receptor (EGFR)-activating mutations in triple-negative breast cancer in China

Wen-Ming Cao  1   2 , Yun Gao  2   3 , Xiao-Jia Wang  4   5
Affiliations

Lack of epidermal growth factor receptor (EGFR)-activating mutations in triple-negative breast cancer in China

Wen-Ming Cao et al. Breast Cancer Res. .
No abstract available

PubMed Disclaimer

References

    1. Teng YH, Tan WJ, Thike AA, Cheok PY, Tse GM, Wong NS, et al. Mutations in the epidermal growth factor receptor (EGFR) gene in triple negative breast cancer: possible implications for targeted therapy. Breast Cancer Res. 2011;13:R35. doi: 10.1186/bcr2857. - DOI - PMC - PubMed
    1. Lv N, Lin S, Xie Z, Tang J, Ge Q, Wu M, et al. Absence of evidence for epidermal growth factor receptor and human homolog of the Kirsten rat sarcoma-2 virus oncogene mutations in breast cancer. Cancer Epidemiol. 2012;36:341–6. doi: 10.1016/j.canep.2012.01.004. - DOI - PubMed
    1. Park HS, Jang MH, Kim EJ, Kim HJ, Lee HJ, Kim YJ, et al. High EGFR gene copy number predicts poor outcome in triple-negative breast cancer. Mod Pathol. 2014;27:1212–22. doi: 10.1038/modpathol.2013.251. - DOI - PubMed
    1. Jacot W, Lopez-Crapez E, Thezenas S, Senal R, Fina F, Bibeau F, et al. Lack of EGFR-activating mutations in European patients with triple-negative breast cancer could emphasise geographic and ethnic variations in breast cancer mutation profiles. Breast Cancer Res. 2011;13:R133. doi: 10.1186/bcr3079. - DOI - PMC - PubMed
    1. Bai H, Wang Z, Chen K, Zhao J, Lee JJ, Wang S, et al. Influence of chemotherapy on EGFR mutation status among patients with non-small-cell lung cancer. J Clin Oncol. 2012;30:3077–83. doi: 10.1200/JCO.2011.39.3744. - DOI - PMC - PubMed

Publication types